PubMed Health⌕ Search

Biomedical subjects

A López Lancis

Publications and source records attributed to A López Lancis.

7 recordsLinked to original sources
PubMed1992

[Epidemiological study of acute poisoning within the population of Zaragoza].

Were chosen for analysis 1443 acute poisonings, that were treated in the Emergency Services of the Miguel Servet Hospital and the University Hospital of Zaragoza between the years 1988 and 89. The great part of the patients didn't required hospitable ingress, it was observed a predominance of the voluntary poisonings with predominance in people under 40 years. Among the drug poisonings were the benzodiazepines the drug more used and among nonpharmacologic agent, alcohol and the narcotics. The treatment more used was the symptomatic (53%) and was contrast the decrease of gastric lavage (15%) and forced diuresis (10%).

Acute Disease↗
PubMed1992

[Cerebellar syndrome as first manifestation of late onset systemic lupus erythematosus].

Clinical characteristics of a 70-year-old women affected by an erythematous systemic lupus (ESL) of late onset, whose first main manifestation was the compromise of the central nervous system as cerebellar syndrome and which exhibited a good response to treatment, is described. Pathogenic and diagnostic aspects of the neurological manifestations of ESL are described.

Aged↗
PubMed1991

[Pulmonary fibrosis as a presentation form of the Jo-1 syndrome].

Jo-1 syndrome is a disease recently described, included on the list of connective tissue diseases. Its clinical features are myositis and/or pulmonary fibrosis associated to the presence of precipitant antibodies against intracellular enzyme call histidine T-RNA synthetase. This antibody is related to pulmonary fibrosis associated to myositis and some scientist gave predictive value on the onset of pulmonary fibrosis in patients with myositis. However, isolated association of pulmonary fibrosis have been exceptionally described. A patient with severe interstitial pulmonary affliction and positive Jo-1 antibody without myositis is presented. The actual knowledge of the disease and its association is reviewed.

Adult↗